Editorial
What’s in a name? The costs and benefits of a formal autism diagnosis
Autism · 2024-02 · 28 (2) · 257-262
DOI: 10.1177/13623613231213300 ↗Kurz gefasst
Editorial in der Zeitschrift Autism, online erschienen am 24.11.2023. Verfasst von Sue Fletcher-Watson. Hauptthemen laut MEDLINE: Autistic Disorder, Autism Spectrum Disorder, Child Development Disorders, Pervasive. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autistic DisorderAutism Spectrum DisorderChild Development Disorders, PervasiveChildHumansCost-Benefit Analysis
Autor:innen und Institutionen
ORCID-Profile: Sue Fletcher-Watson
Zitieren
APA
Fletcher-Watson, S. (2024). What’s in a name? The costs and benefits of a formal autism diagnosis. Autism, 28(2), 257-262. https://doi.org/10.1177/13623613231213300
Vancouver
Fletcher-Watson S. What’s in a name? The costs and benefits of a formal autism diagnosis. Autism. 2024;28(2):257-262. doi:10.1177/13623613231213300
BibTeX
@article{FletcherWatson2024,
author = {Fletcher-Watson, Sue},
title = {What’s in a name? The costs and benefits of a formal autism diagnosis},
journal = {Autism},
year = {2024},
volume = {28},
number = {2},
pages = {257--262},
doi = {10.1177/13623613231213300}
}
EUVIMED